Abstract:Objective To investigate possible changes of lipoprotein(a) [Lp(a)] and oxidized Lp (a) [ox-Lp(a) ] levels after PCI and it mechanisms. Methods Bloods were selected from 75 patients with ACS undergoing PCI, and at 24 hours, 2 and 3 days, and 6 months pre-and post-PCI treatment, and from 29 control patients pre-and post-coronary angiography without undergoing PCI. The levels of Lp(a) , ox-Lp(a) , Lp(a) immune complexes (IC) and its autoantibody were determined by ELISA. The extents of CAD were determined by coronary angiography. The differences of variants pre-and post-operations were analyzed by paired samples t test. The differences of levels of Lp(a) and ox-Lp(a) among time points after PCI were analyzed by ANOVA. Correlations between Lp(a) and ox-Lp(a) , and between angiographic variables and Lp(a), ox-Lp(a) levels were calculated. Results Compared to pre-PCI, Lp(a) [233.10 (152.86-328.79) mg/L vs 202.05 (106.15-271.42) mg/L, t=6. 81, P<0.01], ox-Lp(a) [19.05 (10.98-31.80) mg/L vs 10. 51 (4.98-17.97) μg/ml, t = 13. 22,P <0. 01] and Lp(a)-IC [2.72 (1.604.91) AU vs 2. 11 (1.04-3. 97) AU, t = 3. 34, P < 0. 01 ] levels significantly increased immediately in post-PCI, while its antoantibody levels significantly decreased (A = 0. 81 ± 0. 33 vs A = 0. 72 ± 0. 28, t = 5.58, P < 0. 01). Strong correlations were noted between levels of ox-Lp( a) and Lp( a) both in pre-PCI (r =0. 66, P <0.01) and post-PCI (r = 0. 62, P <0. 01). PCI resulted in rapidrise of Lp(a) and ox-Lp(a) levels and then decreased quickly in 24 hours, returned to baseline in 2-3 days. The changes of Lp(a) and ox-Lp(a) levels in pre-and post-PCI were positively related with severity of ACS. In contrast, in the angiography-only control group, no significant changes were noted in Lp(a) , ox-Lp(a) , Lp(a)-IC and Lp(a) autoantibodies levels between the pre-and post-angiography samples. Conclusion PCI results in acute plasma acute increases of levels of Lp(a) and ox-Lp(a) ,and the changes are related with lesion severity of the coronary artery.

[Changes of Plasma CD40L and PAPP-A in Patients with Acute Coronary Syndrome after the PCI Operation].

Levels Of Pregnancy-Associated Plasma Protein A In Patients With Coronary Artery Disease

Clinical Significance of the Changes of Plasma Adiponectin Levels in Patients with Coronary Artery Disease

Percutaneous coronary intervention results in increases of lipoprotein(a) and oxidized lipoprotein(a) in patients with acute coronary syndrome

The Serum Levels of High Sensitivity C-reactive Protein and Cardiac Events after Percutaneous Coronary Intervention

Impacts of Atherosclerotic Plaque Composition and Platelet Aggregation on Serum Cardiactroponin T Elevation after Percutaneous Coronary Interventions

Percutaneous Coronary Intervention Results in Acute Increases in Native and Oxidized Lipoprotein(a) in Patients with Acute Coronary Syndrome and Stable Coronary Artery Disease.

Changes of Plasma P-selectin、 Thrombomodulin、 Plasminogen Activator Inhibitor-1 of Coronary Artery Disease Patients Before and after PTCA

[Changes of Plasma High-Sensitive C-reactive Protein and Monocyte Chemotactic Factor-1 Following Percutaneous Coronary Interventional Procedures in Patients with Coronary Artery Disease].

Temporal Changes in Circulating P-selectin, Plasminogen Activator Inhibitor-1, Magnesium, and Creatine Kinase after Percutaneous Coronary Intervention

Relationship between PAPP-A and unstable coronary atherosclerotic plaque in patients with acute coronary syndrome

Elevated High Sensitive C-reactive Protein and Apelin Levels after Percutaneous Coronary Intervention and Drug-Eluting Stent Implantation

[Measurement Peripheral Blood Index Related to Inflammation and Ox-Ldl, Ox-Ldlab in Patients with Coronary Heart Disease and Its Clinical Significance].

Level of Pregnancy-Associated Plasma Protein-A Correlates with Coronary Thin-Cap Fibroatheroma Burden in Patients with Coronary Artery Disease Novel Findings from 3-Vessel Virtual Histology Intravascular Ultrasound Assessment

Effects of liposomal prostaglandin E1 on fibrinolytic system in peri-percutaneous coronary interventional in acute coronary syndrome

Effects of Percutaneous Transluminal Coronary Angioplasty on Serum Soluble Intercellular Adhesion Molecule-1 and P-selectin Levels

Influence of concomitant heparin administration on pregnancy-associated plasma protein-A levels in acute coronary syndrome with ST segment elevation

The clinical significance of sCD40L and Lp-PLA2 in the assessment of coronary artery severity and risk classification in patients with non-ST-segment elevation acute coronary syndrome

Change of Level of Platelet Activating Factor after Drug Eluting Stent Implantation in Patients with Stable Coronary Heart Disease and Its Significance

Influence of Serum Apelin and CD40L Expression Levels on Adverse Cardiovascular Events after PCI

Changes of Circulating Endothelial Progenitor Cells in Patients with Coronary Heart Diseases Before and after Percutaneous Coronary Intervention